Literature DB >> 12825076

Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients.

Macarena Gomez-Lira1, Deborah Bonamini, Carlo Castellani, Lorenza Unis, Giorgio Cavallini, Baroukh Maurice Assael, Pier Franco Pignatti.   

Abstract

Idiopathic chronic and acute recurrent pancreatitis (IP) have been associated with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Mutations in the serine protease inhibitor Kazal 1 (SPINK1) have been described in some idiopathic chronic patients and it has been suggested that mutations in this gene could be responsible for a loss of trypsin inhibitor function. In this study, the 5'UTR region, and the four exons and exon-intron boundaries of the SPINK1 gene in 32 IP patients have been analyzed. Three IP patients (9.3%) and one control/100 carried the N34S mutation of the SPINK1 gene (Fisher's exact test, P=0.044). No other mutation that could be associated with an altered function of the SPINK1 protein was observed. The N34S mutation was present in two patients who carried the CFTR-IVS8 5T variant and in one who carried the L997F variant in the CFTR gene. The association of SPINK1 with CFTR gene mutations in IP patients is statistically significant (3/32 IP cases and 0/100 control individuals carrying mutations in both genes; Fisher's exact test P=0.01).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825076     DOI: 10.1038/sj.ejhg.5200989

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  Genetics of acute and chronic pancreatitis: An update.

Authors:  Vv Ravi Kanth; D Nageshwar Reddy
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

2.  Functional significance of SPINK1 promoter variants in chronic pancreatitis.

Authors:  Monique H M Derikx; Andrea Geisz; Éva Kereszturi; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-19       Impact factor: 4.052

3.  Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report.

Authors:  Müjde Soytürk; Göksel Bengi; Dilek Oğuz; İsmail Hakkı Kalkan; Mehmet Yalnız; Mustafa Tahtacı; Kadir Demir; Elmas Kasap; Nevin Oruç; Nalan Gülşen Ünal; Orhan Sezgin; Osman Özdoğan; Engin Altıntaş; Serkan Yaraş; Erkan Parlak; Aydın Şeref Köksal; Murat Saruç; Hakan Ünal; Belkıs Ünsal; Süleyman Günay; Deniz Duman; Alper Yurçi; Sabite Kacar; Levent Filik
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.555

4.  In silico prioritization and further functional characterization of SPINK1 intronic variants.

Authors:  Wen-Bin Zou; Hao Wu; Arnaud Boulling; David N Cooper; Zhao-Shen Li; Zhuan Liao; Jian-Min Chen; Claude Férec
Journal:  Hum Genomics       Date:  2017-05-04       Impact factor: 4.639

5.  Genetic Background and Clinical Characters of Pediatric Chronic Pancreatitis: Data and Implications from the East.

Authors:  Muyun Liu; Tian Xia; Di Zhang; Lianghao Hu; Zhuan Liao; Chang Sun; Zhaoshen Li
Journal:  Gastroenterol Res Pract       Date:  2017-02-28       Impact factor: 2.260

Review 6.  Pancreaticopleural fistula in children with chronic pancreatitis: a case report and literature review.

Authors:  Jia-Yu Zhang; Zhao-Hui Deng; Biao Gong
Journal:  BMC Pediatr       Date:  2020-06-03       Impact factor: 2.125

7.  Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis.

Authors:  Elie Aoun; Chung-Chou H Chang; Julia B Greer; Georgios I Papachristou; M Michael Barmada; David C Whitcomb
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

8.  The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant.

Authors:  Ina Buchholz; Felix Nagel; Annelie Klein; Preshit R Wagh; Ujjwal M Mahajan; Andreas Greinacher; Markus M Lerch; Julia Mayerle; Mihaela Delcea
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-09-13       Impact factor: 3.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.